Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Neuraminidase Inhibitors. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis of influenza neuraminidase inhibitors via Schiff base condensation. Offers scalable routes for antiviral API intermediates with high purity.
Discover advanced synthesis of 1,3,4-oxadiazole neuraminidase inhibitors. Superior potency to Oseltamivir. Reliable pharma intermediate supplier for antiviral drug development.